« Previous
Next »
Fertility and Sterility
Volume 94, Issue 3
, Pages 875-887
, August 2010
Comprehensive chromosome screening of polar bodies and blastocysts from couples experiencing repeated implantation failure
References
- . Increased frequency of female partner chromosomal abnormalities in patients with high-order implantation failure after in vitro fertilization. Fertil Steril. 2002;78:515–519
- . Current value of preimplantation genetic aneuploidy screening in IVF. Hum Reprod Update. 2007;13:15–25
- . ESHRE Preimplantation Genetic Diagnosis Consortium: data collection III (May 2001). Hum Reprod. 2002;(17):233–246
- . Will preimplantation genetic diagnosis assist patients with a poor prognosis to achieve pregnancy?. Hum Reprod. 1997;12:1762–1767
- . Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Hum Genet. 1996;99:755–760
- . Chromosome abnormalities identified by comparative genomic hybridization in embryos from women with repeated implantation failure. Mol Hum Reprod. 2002;8:1035–1041
- Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients. Reprod Biomed Online. 2003;6:232–237
- . Increased susceptibility to maternal aneuploidy demonstrated by comparative genomic hybridization analysis of human MII oocytes and first polar bodies. Cytogenet Genome Res. 2006;114:30–38
- . Diagnosis of major chromosome aneuploidies in human preimplantation embryos. Hum Reprod. 1993;8:2185–2191
- . Increased efficiency of preimplantation genetic diagnosis for infertility using “no result rescue.”. Fertil Steril. 2007;88:53–61
- Variable aneuploidy mechanisms in embryos from couples with poor reproductive histories undergoing preimplantation genetic screening. Hum Reprod. 2007;22:1844–1853
- . Preimplantation diagnosis for aneuploidies in patients undergoing in vitro fertilization with a poor prognosis: identification of the categories for which it should be proposed. Fertil Steril. 1999;72:837–844
- Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertil Steril. 2005;84:331–335
- . Referring Centers PGD Group. Preimplantation genetic diagnosis significantly reduces pregnancy loss in infertile couples: a multi-center study. Fertil Steril. 2006;85:326–332
- Garrisi GJ, Colls P, Ferry KM, Zheng X, Garrisi MG, Munné S. Effect of infertility, maternal age, and number of previous miscarriages on the outcome of preimplantation genetic diagnosis for idiopathic recurrent pregnancy loss. Fertil Steril. Published online August 9, 2008.
- Healthy babies and ongoing pregnancies obtained by preimplantation genetic diagnosis in patients with advanced maternal age and recurrent implantation failure. Hum Reprod. 2000;15:2003–2007
- . High incidence of complex chromosome abnormality in cleavage embryos from patients with repeated implantation failure. Fertil Steril. 2007;87:1053–1058
- . Chromosome analysis of blastomeres from human embryos by using comparative genomic hybridization. Hum Genet. 2000;106:210–217
- . Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod. 2000;6:1055–1062
- Aneuploidy study of human oocytes first polar body comparative genomic hybridization and metaphase II fluorescence in situ hybridization analysis. Hum Reprod. 2004;19:2859–2868
- Comparative genomic hybridization analysis of human oocytes and polar bodies. Hum Reprod. 2006;21:2319–2328
- . Comprehensive molecular cytogenetic analysis of the human blastocyst stage. Hum Reprod. 2008;23:2596–2608
- . Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization. N Engl J Med. 2001;345:1537–1541
- . First clinical application of comparative genomic hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy. Fertil Steril. 2002;78:543–549
- Birth of a healthy boy after a double factor PGD in a couple carrying a genetic disease and at risk for aneuploidy: case report. Hum Reprod. 2008;23:1949–1956
- . Aneuploidy screening of preimplantation embryos using comparative genomic hybridization versus fluorescence in situ hybridization techniques. Fertil Steril. 2003;80:873–874
- . Questions concerning the suitability of comparative genomic hybridization for preimplantation genetic diagnosis. Fertil Steril. 2003;80:871–872
- . Preimplantation diagnosis for aneuploidies using fluorescence in situ hybridization or comparative genomic hybridization. Fertil Steril. 2003;80:869–870
- . Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril. 2007;87:496–503
- . Meiotic and mitotic nondisjunction: lessons from preimplantation genetic diagnosis. Hum Reprod Update. 2004;10:401–407
- . Moving to blastocyst biopsy for preimplantation genetic diagnosis and single embryo transfer at Sydney IVF. Fertil Steril. 2004;82:295–298
- . Pregnancies and live births after trophectoderm biopsy and preimplantation genetic testing of human blastocysts. Fertil Steril. 2005;84:1628–1636
- . Blastocyst trophectoderm biopsy and preimplantation genetic diagnosis for familial monogenic disorders and chromosomal translocations. Prenat Diagn. 2008;29:434–442
- . Blastocyst culture and transfer increases the efficiency of oocyte donation. Fertil Steril. 2000;74:482–486
- . Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil Steril. 1999;72:604–609
- . Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology. 2007;67:73–80
- . Detailed chromosomal and molecular genetic analysis of single cells by whole genome amplification and comparative genomic hybridisation. Nucleic Acids Res. 1999;27:1214–1218
- . Embryo transfer: techniques and variables affecting success. Fertil Steril. 2001;76:863–870
- . Elective transfer of single fresh blastocysts and later transfer of cryostored blastocysts reduces the twin pregnancy rate and can improve the in vitro fertilization birth rate in younger women. Fertil Steril. 2005;84:1620–1627
- . Mosaicism in the inner cell mass of human blastocysts. Hum Reprod. 1998;13:3151–3155
- . Chromosome mosaicism in day 3 aneuploid embryos that develop to morphologically normal blastocysts in vitro. Hum Reprod. 2000;15:1781–1786
- . Developmental ability of chromosomally abnormal human embryos to develop to the blastocyst stage. Hum Reprod. 2001;16:1954–1958
- . Frequency and distribution of chromosome abnormalities in human oocytes. Cytogenet Genome Res. 2005;111:193–198
- Oocyte aneuploidy mechanisms are different in two situations of increased chromosomal risk: older patients and patients with recurrent implantation failure after in vitro fertilization. Fertil Steril. 2007;87:1333–1339
- . Selection of embryos by morphology is less effective than by a combination of aneuploidy testing and morphology observations. Fertil Steril. 2009;91:943–945
- . Maternal aging and chromosomal abnormalities: new data drawn from in vitro unfertilized human oocytes. Hum Genet. 2003;112:195–203
- Sequential FISH analysis of oocytes and polar bodies reveals aneuploidy mechanisms. Prenat Diagn. 2003;23:663–668
- ESHRE PGD Consortium data collection VIII: cycles from January to December 2005 with pregnancy follow-up to October 2006. Hum Reprod. 2008;(12):2629–2645
- . Preimplantation aneuploidy screening using comparative genomic hybridization or fluorescence in situ hybridization of embryos from patients with recurrent implantation failure. Fertil Steril. 2003;80:860–868
E.F. has nothing to disclose. M.K.-J. has nothing to disclose. S.A. has nothing to disclose. J.S. has nothing to disclose. P.C. has nothing to disclose. N.G. has nothing to disclose. S.T. has nothing to disclose. C.G.-M. has nothing to disclose. R.P. has nothing to disclose. W.B.S. has nothing to disclose. S.M. has nothing to disclose. D.W. has nothing to disclose.
D.W. is funded by the National Institute for Health Research Biomedical Research Centre Programme. The authors also received valuable support from the “Once Upon a Time Foundation.”
PII: S0015-0282(09)01078-4
doi: 10.1016/j.fertnstert.2009.04.053
© 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 94, Issue 3
, Pages 875-887
, August 2010

